StockDuty ← Dashboard Oct 30, 2026 08:59 AM ET
SignalEU/UK

AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026 outlook

AstraZeneca beat EPS and revenue estimates by $210M while reaffirming FY2026 outlook.

AstraZeneca beat EPS and revenue estimates by $210M while reaffirming FY2026 outlook.
AstraZeneca beat EPS and revenue estimates by $210M while reaffirming FY2026 outlook. — impact context not separately stored; see What changed.
Sources